A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

Published:2018-08 Issue:2 Volume:150 Page:247-252
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Chan John K.,Brady William,Monk Bradley J.,Brown Jubilee,Shahin Mark S.,Rose Peter G.,Kim Jae-Hoon,Secord Angeles Alvarez,Walker Joan L.,Gershenson David M.

Funder

National Cancer Institute

Gynecologic Oncology Group Statistical Office

NRG Oncology

NRG Operations

Pfizer

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference47 articles.

1. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama;Cancer,2000

2. Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases;Montag;Int. J. Gynecol. Pathol.,1989

3. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers;Chan;Gynecol. Oncol.,2008

4. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a gynecologic oncology group study;Chan;Gynecol. Oncol.,2010

5. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic oncology group study;Chan;Cancer,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological factors of ovarian clear cell carcinoma: A single institutional analysis of 247 cases in China;Biomolecules and Biomedicine;2024-08-13

2. Proteomic landscape of epithelial ovarian cancer;Nature Communications;2024-07-31

3. Status and development of research on clear cell carcinoma of the ovary—a visualization-based bibliometric analysis;Translational Cancer Research;2024-06

4. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer;Journal of Ovarian Research;2024-02-12

5. Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience;Journal of Gynecologic Oncology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3